Efficacy and Safety of IBI303 in Adult Patients With Active Ankylosing Spondylitis
Clinical trial NCT02893254 · COMPLETED
Trial details
- NCT number
- NCT02893254
- Sponsor
- Innovent Biologics (Suzhou) Co. Ltd.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-09-22
- Primary completion
- 2018-01-22
- Enrollment
- 438
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.